newsfilter
← Latest News
GlobeNewswire·

Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors

  • Patrick NJ Schnegelsberg, CEO of Picard Medical & SynCardia Systems, has been elected to the Board of Directors of the Arizona Bioindustry Association (AZBio).
  • His board term will extend through December 2028.
  • AZBio serves as the Arizona affiliate of the Biotechnology Industry Organization (BIO) & AdvaMed.
  • SynCardia Systems, headquartered in Tucson for over two decades, develops the SynCardia Total Artificial Heart (STAH).
  • The STAH is the first & only commercially available total artificial heart approved by both the U.S. FDA & Health Canada.
  • More than 2,100 STAH implants have been performed in 27 countries, making it the most widely used artificial heart globally.
  • The appointment reinforces Picard Medical's commitment to advancing Arizona's life sciences community & patient outcomes.